Technologies Hero Image


In line with the definition of Pharmacovigilance, the Clinical Trials and Pharmacovigilance Department of HBL will function to detect, assess, understand and communicate any adverse event following immunization with a vaccine product manufactured by HBL and prepare Periodic Safety Update Reports (PSUR’s) as per regulatory requirements.

For reporting Adverse Events Following Immunization (AEFI) for vaccine products of HBL, please contact: / Tel Direct no : 044-38008701